Face of Lobbying Changes WTO members led by India and South Africa are pushing for a waiver from Intellectual Property (IP) protections for any goods related to COVID-19. Specifically, they want to freely replicate the vaccines that have been developed by private companies like Pfizer, Moderna, and AstraZeneca. The manufacturers of these drugs argue that the hurdle to having more vaccines available is “complex logistical, engineering, and technical challenges of rapidly scaling-up their manufacture” that would not be resolved by simply giving away the technology. However, the more notable aspect of the manufacturers’ plea to the U.S. government to deny the IP waiver is the coalition it cobbled together in support of...
Key Market Insights The broad market is locked in on this week’s Trump-Xi meeting in Beijing, but this is no longer just a trade summit. Increasingly, the meeting is becoming tied directly to Iran, energy security, and the growing global economic fallout from disruptions through the Strai...
From WPI Consulting
Forecasting developments in production agriculture
On behalf of a private U.S. agricultural technology provider, WPI’s team generated an econometric model to forecast the movement of concentrated corn production north and west from the traditional U.S. Corn Belt. WPI’s model has subsequently provided quantitative support to a multi-million-dollar investment into short-season corn variety development. WPI’s methodology included a series of interviews with regional grain elevators and seed consultants. Emphasizing outreach and communication with stakeholders who possess intimate sectoral knowledge – on-the-ground insights – is a regular component of WPI’s methodologies, made possible by WPI’s ever-growing network of industry contacts.